STEPHEN YENZEN LAI to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications STEPHEN YENZEN LAI has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.054
-
Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation. Semin Radiat Oncol. 2018 04; 28(2):108-113.
Score: 0.031
-
Sorafenib in metastatic thyroid cancer: a systematic review. Oncologist. 2014 Mar; 19(3):251-8.
Score: 0.023